mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.9 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.0028 |
0.9 |